Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High Protein Oral Nutritional Supplements Enable the Majority of Cancer Patients to Meet Protein Intake Recommendations during Systemic Anti-Cancer Treatment: A Randomised Controlled Parallel-Group Study.
Dingemans AM, van Walree N, Schramel F, Soud MY, Baltruškevičienė E, Lybaert W, Veldhorst M, van den Berg CA, Kaasa S. Dingemans AM, et al. Among authors: lybaert w. Nutrients. 2023 Dec 7;15(24):5030. doi: 10.3390/nu15245030. Nutrients. 2023. PMID: 38140289 Free PMC article. Clinical Trial.
A real-world analysis on the efficacy and tolerability of liposomal irinotecan plus 5-fluorouracil and folinic acid in metastatic pancreatic ductal adenocarcinoma in Belgium.
Verbruggen L, Verheggen L, Vanhoutte G, Loly C, Lybaert W, Borbath I, Vergauwe P, Hendrickx K, Debeuckelaere C, de Haar-Holleman A, Van Laethem JL, Peeters M. Verbruggen L, et al. Among authors: lybaert w. Ther Adv Med Oncol. 2023 Aug 18;15:17588359231181500. doi: 10.1177/17588359231181500. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 37600936 Free PMC article.
Proposal of early CT morphological criteria for response of liver metastases to systemic treatments in gastroenteropancreatic neuroendocrine tumors: Alternatives to RECIST.
de Mestier L, Resche-Rigon M, Dromain C, Lamarca A, La Salvia A, de Baker L, Fehrenbach U, Pusceddu S, Colao A, Borbath I, de Haas R, Rinzivillo M, Zerbi A, Funicelli L, de Herder WW, Selberherr A, Wagner AD, Manoharan P, De Cima A, Lybaert W, Jann H, Prinzi N, Faggiano A, Annet L, Walenkamp A, Panzuto F, Pedicini V, Pitoni MG, Siebenhuener A, Mayerhoefer ME, Ruszniewski P, Vullierme MP. de Mestier L, et al. Among authors: lybaert w. J Neuroendocrinol. 2023 Jun;35(6):e13311. doi: 10.1111/jne.13311. Epub 2023 Jun 21. J Neuroendocrinol. 2023. PMID: 37345276
Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer.
Prager GW, Taieb J, Fakih M, Ciardiello F, Van Cutsem E, Elez E, Cruz FM, Wyrwicz L, Stroyakovskiy D, Pápai Z, Poureau PG, Liposits G, Cremolini C, Bondarenko I, Modest DP, Benhadji KA, Amellal N, Leger C, Vidot L, Tabernero J; SUNLIGHT Investigators. Prager GW, et al. N Engl J Med. 2023 May 4;388(18):1657-1667. doi: 10.1056/NEJMoa2214963. N Engl J Med. 2023. PMID: 37133585 Clinical Trial.
Editorial: Insights in head and neck cancer: 2021.
Lybaert W, Vermorken JB. Lybaert W, et al. Front Oncol. 2023 Mar 28;13:1180965. doi: 10.3389/fonc.2023.1180965. eCollection 2023. Front Oncol. 2023. PMID: 37056347 Free PMC article. No abstract available.
NPY Methylated ctDNA is a Promising Biomarker for Treatment Response Monitoring in Metastatic Colorectal Cancer.
Janssens K, Vanhoutte G, Lybaert W, Demey W, Decaestecker J, Hendrickx K, Rezaei Kalantari H, Zwaenepoel K, Pauwels P, Fransen E, Op de Beeck K, Van Camp G, Rolfo C, Peeters M. Janssens K, et al. Among authors: lybaert w. Clin Cancer Res. 2023 May 1;29(9):1741-1750. doi: 10.1158/1078-0432.CCR-22-1500. Clin Cancer Res. 2023. PMID: 36716292 Clinical Trial.
Changes in anticancer treatment plans in patients with solid cancer hospitalized with COVID-19: analysis of the nationwide BSMO-COVID registry providing lessons for the future.
Geukens T, Brandão M, Laenen A, Collignon J, Van Marcke C, Louviaux I, Demey W, Van Wambeke S, Schrijvers D, Lecomte S, Mebis J, Rutten A, Fontaine C, Lybaert W, Aspeslagh S, Goeminne JC, Van Den Bulck H, Seront E, De Backer L, De Roock W, Ignatiadis M, Prenen H, Van Beckhoven D, Heijlen M, Verheezen J, Rottey S, Punie K, de Azambuja E. Geukens T, et al. Among authors: lybaert w. ESMO Open. 2022 Dec;7(6):100610. doi: 10.1016/j.esmoop.2022.100610. Epub 2022 Nov 7. ESMO Open. 2022. PMID: 36356416 Free PMC article.
18F-AlF-NOTA-Octreotide Outperforms 68Ga-DOTATATE/NOC PET in Neuroendocrine Tumor Patients: Results from a Prospective, Multicenter Study.
Pauwels E, Cleeren F, Tshibangu T, Koole M, Serdons K, Boeckxstaens L, Dekervel J, Vandamme T, Lybaert W, den Broeck BV, Laenen A, Clement PM, Geboes K, Cutsem EV, Stroobants S, Verslype C, Bormans G, Deroose CM. Pauwels E, et al. Among authors: lybaert w. J Nucl Med. 2023 Apr;64(4):632-638. doi: 10.2967/jnumed.122.264563. Epub 2022 Oct 20. J Nucl Med. 2023. PMID: 36265911 Free article.
PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment.
Thouvenin J, Van Marcke C, Decoster L, Raicevic G, Punie K, Vandenbulcke M, Salgado R, Van Valckenborgh E, Maes B, Joris S, Steichel DV, Vranken K, Jacobs S, Dedeurwaerdere F, Martens G, Devos H, Duhoux FP, Rasschaert M, Pauwels P, Geboes K, Collignon J, Tejpar S, Canon JL, Peeters M, Rutten A, Van de Mooter T, Vermeij J, Schrijvers D, Demey W, Lybaert W, Van Huysse J, Mebis J, Awada A, Claes KBM, Hebrant A, Van der Meulen J, Delafontaine B, Bempt IV, Maetens J, de Hemptinne M, Rottey S, Aftimos P, De Grève J. Thouvenin J, et al. Among authors: lybaert w. ESMO Open. 2022 Aug;7(4):100524. doi: 10.1016/j.esmoop.2022.100524. Epub 2022 Aug 12. ESMO Open. 2022. PMID: 35970014 Free PMC article.
34 results